Home » News » Awards & Advancement » Immune Design adds Carlos Paya as CEO

Immune Design adds Carlos Paya as CEO

Wednesday, April 27, 2011

Seattle-based vaccine developer Immune Design’s new CEO is Carlos Paya, the former president of Ireland-based biotech Elan. Paya is replacing Immune Design’s founding CEO, Steve Reed, who will continue to serve on the company’s executive management team and board, according to Xconomy Seattle.

At Elan, Paya oversaw commercial, marketing, R&D, and clinical operations since 2008. Before that, he was employed by Eli Lilly as vice president of Lilly Research Laboratories.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!